Search results for "Urothelium"

showing 10 items of 20 documents

Cytokeratins in the Histological Diagnosis of Malignant Tumors

1994

Cytokeratins, which comprise a multigene family of 20 related polypeptides (CKs 1–20), are constituents of the intermediate filaments of epithelial cells, in which they are expressed in various combinations depending on the epithelial type and the degree of differentiation. Of these, CK 19 (400 amino acids; 44.1 kilodaltons) is an example of a widely distributed CK, being expressed in various epithelia, including many simple epithelia. In contrast, the recently identified CK 20 (424 amino acids; 48.6 kilodaltons) is essentially confined to gastrointestinal epithelia, the urothelium and Merkel cells. The differential expression of individual CKs in various types of carcinomas makes them use…

0301 basic medicineCancer ResearchPathologymedicine.medical_specialtyCellular differentiationClinical BiochemistryIntermediate FilamentsGene ExpressionBiologyEpitheliumPathology and Forensic Medicine03 medical and health sciencesCytokeratin0302 clinical medicineNeoplasmsKeratinBiomarkers TumorCarcinomamedicineHumansUrotheliumIntermediate filamentchemistry.chemical_classificationAntibodies MonoclonalCell DifferentiationEpithelial Cellsmedicine.disease030104 developmental biologymedicine.anatomical_structureOncologychemistryTumor progression030220 oncology & carcinogenesisKeratinsMerkel cellThe International Journal of Biological Markers
researchProduct

Behavior of Epithelial Differentiation Antigens (Carcinoembryonic Antigen, Epithelial Membrane Antigen, Keratin and Cytokeratin) in Transitional Cell…

1992

Results of an immunohistochemical study in normal urothelium and transitional cell carcinomas of the bladder are presented. Paraffin-embedded material was confronted with immunoantisera against carcinoembryonic antigen (CEA), keratin (K), cytokeratin (CK) and epithelial membrane antigen (EMA). Immunohistochemical findings confirm the changes in reactivity of dysplastic urothelium and carcinoma in situ for CEA, CK and EMA, in comparison with normal urothelium. Statistically significant differences were also found, depending upon tumor stage, in staining of transitional cell carcinomas for K and CK. Expression of CK correlated with the tumor differentiation grade: normal urothelium and well-d…

AdultMalePathologymedicine.medical_specialtyUrologyurologic and male genital diseasesEpitheliumCytokeratinCarcinoembryonic antigenAntigenAntigens NeoplasmKeratinBiomarkers TumormedicineHumansUrotheliumAgedNeoplasm Stagingchemistry.chemical_classificationCarcinoma Transitional CellMembrane GlycoproteinsbiologyMucin-1Middle Agedmedicine.diseaseAntigens Differentiationfemale genital diseases and pregnancy complicationsCarcinoembryonic AntigenTransitional cell carcinomaUrinary Bladder Neoplasmschemistrybiology.proteinKeratinsImmunohistochemistryFemaleCarcinoma in SituImmunostainingUrologia Internationalis
researchProduct

Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer

2015

PURPOSE: The pentose phosphate pathway (PPP) has been shown to play an important role in the metabolism of cancer cells. The transketolase-like 1 gene (TKTL1) encodes an enzyme representing an essential component of this pathway. Its expression has been demonstrated to correlate with stage and outcome in various tumors. The aim of the present study was to assess expression patterns and the prognostic role of TKTL1 in muscle-invasive bladder cancer (MIBC). PATIENTS AND METHODS: The expression of TKTL1 was assessed in a tissue microarray consisting of histopathologically benign and malign tissue of 112 patients who underwent radical cystectomy due to MIBC. Cytoplasmatic and nuclear expression…

AdultMalemedicine.medical_specialtyGlycolysiUrologymedicine.medical_treatmentBiopsyDiabetePentose phosphateSettore MED/24 - UrologiaCystectomyInternal medicineBiopsymedicineHumansNeoplasm InvasivenessUrotheliumLymph nodeAgedRetrospective StudiesAged 80 and overBladder cancerTissue microarraymedicine.diagnostic_testbusiness.industryBladder cancerTransketolase-like 1DNA NeoplasmBiomarkerMiddle Agedmedicine.diseaseImmunohistochemistryGene Expression Regulation Neoplasticmedicine.anatomical_structureEndocrinologyUrinary Bladder NeoplasmsTissue Array AnalysisCancer cellCancer researchImmunohistochemistryFemaleTransketolaseUrotheliumbusinessFollow-Up Studies
researchProduct

Inhibition of human detrusor contraction by a urothelium derived factor.

2003

Stimulating muscarinic receptors in pig bladder urothelium causes the release of a diffusable factor that inhibits contractions of the underlying detrusor muscle. We investigated whether the contractions of human detrusor strips elicited by the muscarinic agonist carbachol, electrical field stimulation, KCl or the neurokinin receptor agonist neurokinin A are affected by the urothelium.Paired intact and urothelium denuded muscle strips were placed in modified gassed Tyrode's solution at 37C. Cumulative concentration-response curves to carbachol or KCl were constructed. In other tissues the strips were stimulated electrically (1 to 40 Hz) with trains of square wave pulses 20 seconds in durati…

AgonistDetrusor muscleMalemedicine.medical_specialtyCarbacholmedicine.drug_classUrologyNeurokinin APig bladderMuscarinic Agonistsurologic and male genital diseasesMuscarinic agonistPotassium Chloridechemistry.chemical_compoundInternal medicineCulture TechniquesMuscle HypertoniamedicineHumansUrotheliumAgedDose-Response Relationship Drugurogenital systembusiness.industryTissue ExtractsMuscle SmoothMiddle Agedfemale genital diseases and pregnancy complicationsElectric StimulationStimulation ChemicalEndocrinologymedicine.anatomical_structurechemistryCarbacholFemaleNeurokinin Amedicine.symptomUrotheliumbusinessmedicine.drugMuscle contractionMuscle ContractionThe Journal of urology
researchProduct

Therapeutic Modulation of Urinary Bladder Function: Multiple Targets at Multiple Levels

2015

Storage dysfunction of the urinary bladder, specifically overactive bladder syndrome, is a condition that occurs frequently in the general population. Historically, pathophysiological and treatment concepts related to overactive bladder have focused on smooth muscle cells. Although these are the central effector, numerous anatomic structures are involved in their regulation, including the urothelium, afferent and efferent nerves, and the central nervous system. Each of these structures involves receptors for—and the urothelium itself also releases—many mediators. Moreover, hypoperfusion, hypertrophy, and fibrosis can affect bladder function. Established treatments such as muscarinic antago…

Central Nervous Systemmedicine.medical_specialtyUrinary BladderPopulationCentral nervous systemMuscarinic Antagonistsurologic and male genital diseasesToxicologyBioinformaticsMuscle hypertrophyNeurons EfferentFibrosisInternal medicinemedicineAnimalsHumansNeurons AfferentUrotheliumeducationPharmacologyeducation.field_of_studyUrinary bladderbusiness.industryUrinary Bladder DiseasesMuscle SmoothAdrenergic beta-AgonistsHyperplasiamedicine.diseasefemale genital diseases and pregnancy complicationsUrodynamicsTreatment OutcomeEndocrinologymedicine.anatomical_structureOveractive bladderAdrenergic alpha-1 Receptor AntagonistsUrological AgentsUrotheliumbusinessSignal TransductionAnnual Review of Pharmacology and Toxicology
researchProduct

Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma

2005

Renal cell carcinoma (RCC) representing the most common neoplasia of the kidney in Western countries is a histologic diverse disease with an often unpredictable course. The prognosis of RCC is worsened with the onset of metastasis, and the therapies currently available are of limited success for the treatment of metastatic RCC. Although gene expression analyses and other methods are promising tools clarifying and standardizing the pathological classification of RCC, novel innovative molecular markers for the diagnosis, prognosis, and for the monitoring of this disease during therapy as well as potential therapeutic targets are urgently needed. Using proteome-based strategies, a number of RC…

DiseaseBiologyFatty Acid-Binding ProteinsKidneyurologic and male genital diseasesmedicine.disease_causeBiochemistryMetastasisReference ValuesRenal cell carcinomaCell Line TumorBiomarkers TumormedicineCarcinomaHumansElectrophoresis Gel Two-DimensionalUrotheliumCarcinoma Renal CellneoplasmsMolecular BiologyDNA PrimersKidneyReverse Transcriptase Polymerase Chain ReactionPrognosismedicine.diseaseImmunohistochemistryKidney Neoplasmsfemale genital diseases and pregnancy complicationsGene Expression Regulation Neoplasticmedicine.anatomical_structureImmunologyDisease ProgressionCancer researchUrotheliumCarrier ProteinsCarcinogenesisKidney diseasePROTEOMICS
researchProduct

Identification of ELF3 as an early transcriptional regulator of human urothelium

2014

AbstractDespite major advances in high-throughput and computational modelling techniques, understanding of the mechanisms regulating tissue specification and differentiation in higher eukaryotes, particularly man, remains limited. Microarray technology has been explored exhaustively in recent years and several standard approaches have been established to analyse the resultant datasets on a genome-wide scale. Gene expression time series offer a valuable opportunity to define temporal hierarchies and gain insight into the regulatory relationships of biological processes. However, unless datasets are exactly synchronous, time points cannot be compared directly.Here we present a data-driven ana…

Hepatocyte Nuclear Factor 3-alphaTime seriesTime FactorsPPARγMicroarrayNormal Human UrotheliumComputational biologyBiologyReal-Time Polymerase Chain ReactionBioinformaticsProto-Oncogene ProteinsGene expressionElectric ImpedanceTranscriptional regulationHumansRNA Small InterferingGeneTranscription factorMolecular BiologyDNA PrimersGene knockdownProto-Oncogene Proteins c-etsReverse Transcriptase Polymerase Chain ReactionMicroarray analysis techniquesGene Expression Regulation DevelopmentalCell DifferentiationCell BiologyMicroarray AnalysisImmunohistochemistryELF3DNA-Binding ProteinsDifferentiationGene Knockdown TechniquesGene chip analysisGene expressionUrotheliumTranscription FactorsDevelopmental BiologyDevelopmental Biology
researchProduct

Aquaporin 3 Expression Loss in Urothelial Carcinoma: Association with Tumor Invasion Depth, but not with Grading?

2017

We have previously provided molecular evidence of expression of aquaporin 3 (AQP3) in normal human urothelium and in UBC of various stages. Whereas former studies demonstrated that loss of AQP3 was associated with invasive and high-grade disease and worse progression-free and cancer-specific survival, this report investigates the expression of AQP3 in associated CIS. Contrary to what we had expected, all CIS specimens were shown to exhibit strong AQP3 expression, suggesting loss of AQP3 in UBC is primarily associated with the ability of tumor cells for invasion but not with grading as sign of dedifferentiation.

Invasion depthPathologymedicine.medical_specialtyUrologyCarcinoma in situShort CommunicationBladder030232 urology & nephrologycarcinoma in situMolecular evidenceBiologymedicine.disease03 medical and health sciences0302 clinical medicineOncologyAquaporin 3030220 oncology & carcinogenesisimmunohistochemistrymedicineImmunohistochemistryUrotheliumaquaporin 3Grading (tumors)urothelial carcinomaUrothelial carcinomaBladder Cancer (Amsterdam, Netherlands)
researchProduct

Studies on the Intravesical Action of Topically Administered G 3 H-Doxorubicin Hydrochloride in Men: Plasma Uptake and Tumor Penetration

1980

AbstractDoxorubicin hydrochloride has been used for the treatment and prevention of recurrences of transitional cell carcinoma. Ideal indications for the drug and side effects have not been determined. In this regard the penetration of the drug into the bladder wall and the urothelium as a urinary blood barrier is of interest. Using a tritium label we have investigated tumor penetration and transmucosal plasma uptake of doxorubicin hydrochloride after intravesical application in 7 patients with stage A bladder tumors. Of the 7 patients 5 were free of tumor following transurethral resection and 2 had recurrent disease. The patients free of tumor received 40mg. doxorubicin hydrochloride per 3…

MaleDrugmedicine.medical_specialtyPathologyHydrochlorideAdministration TopicalUrologymedia_common.quotation_subjectUrinary systemmedicine.medical_treatmentUrinary BladderUrologychemistry.chemical_compoundHumansMedicineUrotheliumSalinemedia_commonCarcinoma Transitional Cellbusiness.industryPapillary tumorMiddle Agedmedicine.diseaseTransitional cell carcinomaUrinary Bladder NeoplasmschemistryDoxorubicinDoxorubicin HydrochlorideNeoplasm Recurrence LocalbusinessJournal of Urology
researchProduct

Immunoexpression of adrenergic receptors in detrusor from patients with prune belly syndrome: a digital quantification

2010

Abstract Introduction Prune belly syndrome (PBS) presents with large-capacity bladders, high compliance and post-void residual volumes. Operative and conservative treatments are controversial. When histologically compared to normal bladder, bladder outlet obstruction results in an up- or down-regulation of adrenoceptors. Our goal was to study the immunoexpression of adrenoceptors in detrusor from patients with PBS. Materials and methods Bladder domes from PBS patients ( n  = 14) were studied (PBG). For normal controls, bladder specimens were obtained at adult surgery ( n  = 13) (CG1) and at child autopsy ( n  = 5) (CG2). Staining was performed using antibodies to α1a, α1b, α1d and β3 adreno…

MalePhotomicrographymedicine.medical_specialtyAdrenergic receptorUrologyArbitrary unitUrinary BladderUrologyAutopsyAntibodiesBladder outlet obstructionPrune belly syndromeReceptors Adrenergic alpha-1Image Processing Computer-AssistedHumansPrune Belly SyndromeMedicineReceptorRetrospective Studiesbusiness.industryInfantAnatomyMiddle Agedmedicine.diseaseImmunohistochemistryReceptors AdrenergicUrinary Bladder Neck ObstructionReceptors Adrenergic beta-3Pediatrics Perinatology and Child HealthDisease ProgressionImmunohistochemistryFemaleUrotheliumbusinessBiomarkersImmunostainingJournal of Pediatric Urology
researchProduct